Paranasal Malignancies occurs when the cells lining the nasal cavity, the sinus passages and the nasopharynx – which is the area behind the nose above the back of the throat become cancerous. Generally, nose cancer affects men more than women, and typically occurs between the ages of 35 and 55.
A nasendoscope (a flexible tube with a very small telescope at the end, which is passed into one of your nostrils) is inserted through the nose to look for abnormal growths. If there are any signs of disease a biopsy is taken of the abnormal tissue to look for any cancer cells.
Treatment for nose cancer various on the location of the cancer also the extent of the disease. As well as if it has spread and how far. Treatment options include Radiotherapy, Chemotherapy or Surgery. If detected early surgery may be the only treatment needed. Chemotherapy is used to improve the outcomes for the patient following their surgery. Chemotherapy may also be used in combination with radiotherapy to improve the efficiency of radiotherapy.
In majority of cases a neurosurgeon is present and the surgery is performed jointly. Following surgery a short stay in intensive care is recommended and the patient is usually discharged after 5 days if there are no problems.
The major post operative problems that we look for are CSF leak (cerebrospinal fluid leak), if this occurs the patient will need to stay in hospital for a longer period of time until it stops.
Dr Ananda operates at Royal Prince Alfred Hospital and Chris O’Brien LifeHouse along with Neurosurgeons.